New Treatment Soothes Rosacea Outbreaks
Finacea Gel Reduces Rosecea's Redness Better Than Acne Treatment
Nov. 17, 2003 -- A new gel specifically formulated to ease the
skin irritation caused by rosacea works better than a popular acne gel commonly
used in rosacea treatment.
New research shows that Finacea gel, which was approved by the
FDA in January for rosacea treatment, reduces the redness and lesions
associated with rosacea better than Metrogel.
Rosacea (pronounced row-ZAY-shuh) is a chronic skin condition
that results in red, flaky patches on the nose and cheeks and occasional
pimple-like lesions on the skin. About 14 million Americans have rosacea, and
the condition usually strikes adults between the ages of 30 and 60.
Although the exact cause of rosacea is unknown, antimicrobial
skin creams and gels that kill bacteria are often used in treating acne are
also frequently used in treating the skin irritation associated with
New Gel Eases Rosacea
Both Metrogel and Finacea are antimicrobial skin gels, but they
have different active ingredients. Financea contains 15% azelaic acid, and
Metrogel contains 0.75% metronidazole gel.
In this study, published in the November issue of The
Archives of Dermatology, researchers compared the two treatments in 251
adults with rosacea. Each patient used either Finacea or Metrogel twice a day
for 15 weeks.
The study showed that Financea was better than Metrogel at
reducing the number of acne-like lesions associated with rosacea. In addition,
56% of Finacea users experienced a reduction in redness compared with 42% of
Researchers also found that the effectiveness of Metrogel
seemed to plateau after eight weeks of use, but patients using Finacea
experienced continuous improvement over 15 weeks.
Researcher Boni E. Elewski, MD, of the University of Alabama at
Birmingham, and colleagues say the findings show that Finacea might be an
effective long-term treatment for rosacea, and more research in this area is